Status
Conditions
Treatments
About
START study is a comparison of cost-utility between permanent pacemaker replacement ambulatory care and permanent pacemaker replacement conventional hospitalization care.
The hypothesis of the study is that ambulatory care compared to conventional hospitalization, involving a stay of more than 24 hours, would reduce hospitalization and care expenses without loss of quality of care and without increasing the complication rate for patients.
Full description
In France, nearly 49,000 permanent pacemakers are implanted each year. The pacemaker longevity is about 10 years which leads to their replacement.
In France, in 2016, 15,764 pacemaker replacement hospital stays took place. 10.6% of them were made during an outpatient stay, 12.4% during a one-night hospitalization and 70.7% during hospitalization for two or more than two nights for the severity level 1.
If the outpatient care management is deployed at 90%, the economy of the cost care will be estimated to be 3,5 million euros and a reduction of 15 582 hospitalization night's stay.
The aim of START study is to compare cost-utility between ambulatory and conventional hospitalization care of permanent pacemakers replacement for elective replacement indicator and to demonstrate equivalence between outpatient management and conventional hospitalization management.
This study is in adequation with the national ambition to deploy the outpatient management in France. Surgery is the same with both hospitalization managements.
An ambulatory surgery need to present different advantages and benefits like high quality care and substantial cost savings.
The benefits of ambulatory care management are :
Surgery is the same with both hospitalization managements.
Patients will be randomized in 2 arms. An arm conventional hospitalization management (control arm) and an arm outpatient care management.
Study period is 30 months. Patients will be following during 6 months. The recruitment time will be 24 months.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
750 participants in 2 patient groups
Loading...
Central trial contact
Imen Fellah; Vincent Probst
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal